PARASTERNAL BLOCKADE
- Conditions
- Parasternal BlockCardiac SurgerySerum Lactate
- Interventions
- Procedure: parasternal blockDiagnostic Test: Lactate serum level
- Registration Number
- NCT06608290
- Lead Sponsor
- Instituto Mexicano del Seguro Social
- Brief Summary
Parasternal blockade has been related to a reduction of the postoperative inflammatory response, by inhibition of the stress response, leading to a better prognosis. Increased lactate level is a useful parameter in identifying patients at risk of postoperative morbidity and mortality. The objective was to evaluate the association between parasternal blockade and serum lactate level in patients undergoing cardiac surgery, both trans- and post-anesthesia. 86 patients between 60-70 years of age participated. An association was found between the application of parasternal blockade in cardiac surgery and the presence of lower trans and postanesthetic serum lactate levels.
- Detailed Description
An analytical cross-sectional study in adult patients who underwent elective cardiac surgery. A total sample of 86 patients was obtained, 43 in the case group and 43 in the control group. Adult patients older than 18 years, of either sex, with ASA II-III, patients who underwent cardiac surgery with median sternotomy and use of cardiopulmonary bypass were included.
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 86
Not provided
Not provided
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description Blockade parasternal block In patients which parasternal block has been applied Blockade Lactate serum level In patients which parasternal block has been applied Control Lactate serum level In patients which parasternal block has not been applied
- Primary Outcome Measures
Name Time Method Lactate serum levels 24 Hours Blood samples were taken to identify serum lactate levels greater than 2 mmol/l and those that remained below this limit.
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (1)
Unidad de Investigación Biomédica 02, Unidad Médica de alta especialidad, Hospital de Especialidades Centro Médico Nacional de Occidente, Instituto Mexicano del Seguro Social, Guadalajara 44329, México
🇲🇽Guadalajara, Jalisco, Mexico